Recent posts

TypePostAuthorRepliesLast updated
Book pagePrizes to stimulate innovation James Love044 weeks 5 days ago
Blog entryObama administration blocking consensus at Human Rights Council on access to medicines resolution thiru044 weeks 6 days ago
Page2016: KEI comments on NIH proposal for exclusive licenses to Lentigen Technology, Inc. Diane Singhroy045 weeks 2 days ago
Page2016: KEI comments on NIH proposal for exclusive licenses to IntelliPanel Medical, LLC Diane Singhroy045 weeks 2 days ago
Page2016: KEI comments on NIH proposal for exclusive licenses to Etubics Corporation Diane Singhroy045 weeks 2 days ago
Page2016: KEI comments on NIH proposal for exclusive licenses to Dimension Therapeutics, Inc. Diane Singhroy045 weeks 2 days ago
Blog entryAlfred Engelberg and Aaron Kesselheim in Nature on Bayh-Dole royalty free rights in patents, Xtandi case James Love045 weeks 2 days ago
Blog entryColombia Ministry of Health Announces that Negotiations With Novartis Have Failed; Declaration of Public Interest Imminent Andrew Goldman045 weeks 3 days ago
Blog entryXtandi patient on Medicare — with supplement — pays $441.97 per month Zack Struver045 weeks 3 days ago
Blog entryUS proposal to seek a "better understanding" of Switzerland's implementation of the Nagoya Protocol receives chilly reception thiru045 weeks 4 days ago
Blog entryWIPO IGC30: Narrowing existing gaps relating to the protection of genetic resources? Staff045 weeks 5 days ago
Blog entryWIPO IGC30: Clean and track-changed version of Facilitators' text on Intellectual Property and Genetic Resources thiru045 weeks 5 days ago
PageWIPO IGC30 thiru045 weeks 5 days ago
Blog entry28 Organizations Ask President Obama to Support Colombian Compulsory License on Expensive Leukemia Drug Zack Struver046 weeks 4 days ago
Blog entryHAI/KEI intervention at the WHA69 on the negotiations on an R&D agreement KEI Staff046 weeks 5 days ago
Blog entryHAI/KEI intervention at the WHA69 on the Framework of Engagement with Non-State Actors thiru046 weeks 5 days ago
Blog entrySens. Sherrod Brown and Bernie Sanders send letter to USTR condemning pressure on Colombia compulsory license for cancer drug Andrew Goldman047 weeks 1 day ago
Blog entryLetter from KEI, Public Citizen, Oxfam America and Health GAP to Senator Hatch, regarding Colombia Compulsory License James Love047 weeks 2 days ago
Blog entryHarvard's Oct. 23, 2015 forum on "Drug Pricing: Public Health Implications" Zack Struver047 weeks 2 days ago
PageColombia James Love047 weeks 2 days ago
Blog entrySenator Hatch Defends Pressure on Colombia in Interview Regarding Imatinib Andrew Goldman047 weeks 2 days ago
Blog entry15 House Dems Press USTR to Clarify Position on Compulsory Licensing of cancer drug patent in Colombia Andrew Goldman047 weeks 2 days ago
Blog entryWHA 69: Colombian Minister of Health Calls on WHO to Support the Regulation of Drug Monopolies Andrew Goldman047 weeks 3 days ago
Book pageDelinkage James Love047 weeks 4 days ago
PageWHO at the crossroads: negotiations to fund global R&D mired in eight pages of [bracketed] text thiru048 weeks 17 hours ago